293780 — AptaBio Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for AptaBio Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	46,158	42,825	22,911	16,995	51,885
Net Total Accounts Receivable
Net Total Receivables	323	680	479	3,047	2,659
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46,767	43,745	23,777	20,419	57,474
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,033	4,889	4,822	5,848	5,129
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	77,404	75,444	64,911	56,114	92,519
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	731	801	788	1,040	818
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	2,249	3,403	3,246	3,744	38,192
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	75,155	72,040	61,665	52,370	54,327
Total Liabilities & Shareholders' Equity	77,404	75,444	64,911	56,114	92,519
Total Common Shares Outstanding
Total Preferred Shares Outstanding